Shaad Essa Abedin

Dad, passionate explorer, science enthusiast, practicing physician scientist - developing new treatments - previously at Einstein, UTexas, AZ, & Immunocore

[Quetzal Therapeutics @Quetzal_Tx]

We’re excited to share that QTX-2101, our oral arsenic trioxide capsule, has been granted FDA Fast Track designation for the treatment of acute promyelocytic leukemia!

Read the full press release here:
https://t.co/zcswpiEVpj

[Rare Diseases @CheckOrphan]

Quetzal Therapeutics Launches Phase III Clinical Trial of Oral QTX-2101 for Acute Promyelocytic Leukemia (APL) - For More Visit https://t.co/BKjqGiAtg4 #Leukemia #Acute_Promyelocytic_Leukemia #APL #Quetzal

[Shaad Essa Abedin @shaadessa]

@BalazsHalmosMD Congratulations!

[Shaad Essa Abedin @shaadessa]

Lasker awardee Svetlana Mojsov describes a yearlong journey out of obscurity | Science | AAAS https://t.co/YH1b9OiIP8

[Balazs Halmos @BalazsHalmosMD]

#ASCOLung

How it started How it is going

[Shaad Essa Abedin @shaadessa]

Excited to hear @carlhjune speaking at Unlocking complex cell-based gene therapies. Thanks to @CancerResrch @parkerici

[Shaad Essa Abedin @shaadessa]

@DrOlaLandgren @theMMRF @IMFmyeloma Congratulations on your phenomenal achievement!

[Shaad Essa Abedin @shaadessa]

#Eclipse

[Shaad Essa Abedin @shaadessa]

Embracing cancer complexity: Hallmarks of systemic disease: Cell ⁦@CellCellPress⁩ https://t.co/51P3y8hQPf

[nature @Nature]

A person has received an experimental treatment for the first time that, if successful, will lead them to grow an additional, ‘miniature liver’ https://t.co/6OyZDEo9D2

[Shaad Essa Abedin @shaadessa]

The TUBB4B gene coding tubulin, had significant association with left-handedness, which indicates that microtubules may be crucial to the human brain asymmetry involved in hand dominance. ⁦@Nature⁩ https://t.co/FEI4U32AIF

[Shaad Essa Abedin @shaadessa]

Pretty cool! Brain implant can transmit thought to action. Hoping advances like these can help more people. @neuralink

[Neuralink @neuralink]

https://t.co/OMIeGGjYtG

[NEJM @NEJM]

A novel CAR T-cell therapy directed at EGFRvIII with a secretable EGFR T-cell engager produced rapid responses in three patients with recurrent glioblastoma, but the responses were transient in two of the three. Read the Brief Report for the full study: https://t.co/kYAm6U9DR1

[David Gandara @drgandara]

Hot off the press! “Multi-omics” approach (genomics, epigenomics, proteomics) to plasma testing proves effective in colorectal cancer screening. Hoping same will be seen in other cancer types @NEJM @ASCO @isliquidbiopsy

[Montefiore Health System @MontefioreNYC]

We are profoundly grateful that Dr. Ruth Gottesman, Professor Emerita of Pediatrics at @EinsteinMed, has made a transformational gift to #MontefioreEinstein—the largest to any medical school in the country—that ensures no student has to pay tuition again. https://t.co/XOy9HZLbfD

[NEJM @NEJM]

Original Article: CD19 CAR T-Cell Therapy in Autoimmune Disease — A Case Series with Follow-up https://t.co/6SCCz0DCIW

Editorial: CAR T Cells — A New Horizon for Autoimmunity? https://t.co/bEtblptmE9

#MedTwitter

[Shaad Essa Abedin @shaadessa]

MEGA-CRISPR tool gives a power boost to cancer-fighting cells https://t.co/vwbUh4km4k @Nature

[Nature Reviews Drug Discovery @NatRevDrugDisc]

FDA approves first tumour-infiltrating lymphocyte therapy, bolstering hopes for cell therapies in solid cancers https://t.co/1yDwyZsKGa

Iovance’s lifileucel for patients with melanoma is the result of >30 years of research on this cell therapy modality https://t.co/blKal3nZzY

[Shaad Essa Abedin @shaadessa]

Shocking loss 😔 https://t.co/hYHrpgKunE

[Shaad Essa Abedin @shaadessa]

@thenasheffect @NIH @NIHDirector @EladSharonMD @NCICTEP_ClinRes @StephensonCC Congratulations Rafeh!